{"name": "Aesica Pharmaceuticals",
 "permalink": "aesica-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/aesica-pharmaceuticals",
 "homepage_url": "http://www.aesica-pharma.co.uk/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@aesica-pharma.com",
 "phone_number": "+44 (0)1670 590595",
 "description": "",
 "created_at": "Sat Oct 01 02:47:01 UTC 2011",
 "updated_at": "Sat Oct 01 02:46:59 UTC 2011",
 "overview": "\u003Cp\u003EAesica Pharmaceuticals Ltd. develops, manufactures, and supplies active pharmaceutical ingredients, formulations, and custom synthesis solutions to biotechnology organizations, pharmaceuticals, and generic manufacturers. It offers contract manufacturing services for various formulated products, including anti-Infective, cardiovascular, anti-viral, anesthetics, anti-inflammatory, haemostatic, hormones, and potent drugs. The company was founded in 2004 and is headquartered in Newcastle upon Tyne, the United Kingdom with additional offices in Tyne and Wear, Cramlington, Ponders End, Queenborough, New Jersey, and Shanghai. Aesica Pharmaceuticals Ltd. is a prior subsidiary of BASF SE.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       41],
      "assets/images/resized/0015/6323/156323v1-max-150x150.png"],
     [[218,
       60],
      "assets/images/resized/0015/6323/156323v1-max-250x250.png"],
     [[218,
       60],
      "assets/images/resized/0015/6323/156323v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Robert",
      "last_name": "Hardy",
      "permalink": "robert-hardy-3",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "Nick",
      "last_name": "Jones",
      "permalink": "nick-jones-3",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.finsmes.com/2011/09/aesica-pharmaceuticals-receives-majority-investment-silverfleet-capital.html?utm_source=feedburner\u0026utm_medium=feed\u0026utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29",
    "source_description": "Aesica Pharmaceuticals Receives Majority Investment from Silverfleet Capital",
    "raised_amount": null,
    "raised_currency_code": null,
    "funded_year": 2011,
    "funded_month": 9,
    "funded_day": 30,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Windmill Industrial Estate",
    "address2": "Shotton Lane, Cramlington",
    "zip_code": "NE23 3JL",
    "city": "Northumberland",
    "state_code": null,
    "country_code": "GBR",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}